News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
467,817 Results
Type
Article (17276)
Company Profile (130)
Press Release (450411)
Section
Business (149418)
Career Advice (826)
Deals (25508)
Drug Delivery (31)
Drug Development (41927)
Employer Resources (72)
FDA (10330)
Job Trends (9478)
News (229630)
Policy (16582)
Tag
Academia (1399)
Alliances (39490)
Alzheimer's disease (597)
Approvals (10343)
Artificial intelligence (211)
Bankruptcy (186)
Best Places to Work (7697)
Biotechnology (101)
Breast cancer (123)
Cancer (1016)
Career advice (721)
CAR-T (89)
Cell therapy (265)
Clinical research (33568)
Collaboration (551)
Compensation (184)
COVID-19 (1232)
C-suite (132)
Data (1010)
Diabetes (97)
Diagnostics (5323)
Earnings (59131)
Events (72369)
Executive appointments (447)
FDA (10896)
Funding (454)
Gene editing (74)
Gene therapy (159)
GLP-1 (263)
Government (1460)
Healthcare (12221)
Infectious disease (1300)
Interviews (98)
IPO (11899)
Job creations (2099)
Job search strategy (647)
Layoffs (184)
Legal (3999)
Lung cancer (123)
Manufacturing (158)
Medical device (12094)
Medtech (12099)
Mergers & acquisitions (13923)
Metabolic disorders (235)
Neuroscience (794)
NextGen: Class of 2025 (4301)
Non-profit (1953)
Northern California (1415)
Obesity (106)
Opinion (98)
Patents (115)
People (42734)
Phase I (11449)
Phase II (14892)
Phase III (10472)
Pipeline (555)
Postmarket research (990)
Preclinical (4914)
Radiopharmaceuticals (192)
Rare diseases (163)
Real estate (4147)
Regulatory (11922)
Research institute (1385)
Resumes & cover letters (124)
Series A (81)
Southern California (1277)
Startups (2810)
United States (12703)
Vaccines (299)
Date
Last 7 days (538)
Last 30 days (1713)
Last 365 days (23060)
2025 (3519)
2024 (23912)
2023 (28220)
2022 (37973)
2021 (40235)
2020 (38228)
2019 (31602)
2018 (23944)
2017 (23273)
2016 (22000)
2015 (26342)
2014 (19973)
2013 (16604)
2012 (17926)
2011 (18541)
2010 (17313)
Location
Africa (424)
Arizona (129)
Asia (28160)
Australia (4761)
California (3307)
Canada (1235)
China (218)
Colorado (167)
Connecticut (162)
Europe (59943)
Florida (487)
Georgia (125)
Illinois (297)
Indiana (165)
Japan (100)
Kansas (83)
Maryland (458)
Massachusetts (2417)
Michigan (186)
Minnesota (272)
New Jersey (936)
New York (903)
North Carolina (614)
Northern California (1415)
Ohio (116)
Pennsylvania (650)
South America (657)
Southern California (1277)
Texas (480)
Utah (99)
Washington State (343)
467,817 Results for "sensient technologies corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Sensient Technologies Corporation Reports Results for the Quarter Ended March 31, 2024 and Raises Full Year Guidance
Sensient Technologies Corporation, a leading provider of flavors and colors for the food, pharmaceutical, and personal care markets, reported financial results for the first quarter ended March 31, 2024.
April 26, 2024
·
16 min read
Business
Sensient Technologies Corporation Reports Results for the Quarter Ended December 31, 2023
Sensient Technologies Corporation, a leading provider of flavors and colors for the food, pharmaceutical, and personal care markets, reported financial results for the fourth quarter ended December 31, 2023.
February 8, 2024
·
22 min read
Press Releases
Sensient Declares Dividend - October 24, 2024
October 25, 2024
·
1 min read
BioMidwest
Sensient Declares Dividend - Jan 19, 2024
The Board of Directors of Sensient Technologies Corporation has declared a regular quarterly cash dividend on its common stock of $0.41 per share.
January 19, 2024
·
1 min read
BioMidwest
Sensient Announces Conference Call - Jan 26, 2024
Sensient Technologies Corporation will hold its conference call to discuss 2023 fourth quarter and year-end results at 8:30 a.m. CST on Friday, February 9, 2024.
January 26, 2024
·
1 min read
BioMidwest
Sensient Announces Conference Call - October 06, 2023
Sensient Technologies Corporation will hold its conference call to discuss 2023 third quarter results at 8:30 a.m. CDT on Friday, October 20, 2023.
October 6, 2023
·
1 min read
Business
Sensient Technologies Corporation Reports Results for the Quarter Ended March 31, 2023
Sensient Technologies Corporation reported consolidated revenue of $369.0 million in this year’s first quarter compared to $355.5 million in last year’s first quarter.
April 28, 2023
·
8 min read
BioMidwest
Sensient Announces Conference Call - July 07, 2023
Sensient Technologies Corporation will hold its conference call to discuss 2023 second quarter results at 8:30 a.m. CDT on Friday, July 21, 2023.
July 7, 2023
·
1 min read
Business
Sensient Technologies Corporation Reports Results for the Quarter Ended December 31, 2022
Sensient Technologies Corporation reported consolidated revenue of $348.7 million in this year’s fourth quarter compared to $340.4 million in last year’s fourth quarter.
February 10, 2023
·
10 min read
Business
Sensient Technologies Corporation Announces Retirement of Dr. Elaine R. Wedral from its Board of Directors
Sensient Technologies Corporation Announces Retirement of Dr. Elaine R. Wedral from its Board of Directors.
December 9, 2022
·
1 min read
1 of 46,782
Next
